BAX

MKT CAP:$12B

Baxter International Inc

Market Cap

$12B

Healthcare·Medical Instruments & Supplies·🇺🇸 United States·NYSE

Healthcare·Medical·🇺🇸·NYSE

Stock Price

$22.15+$2.67 (+13.70%)

Jul 15, 2026

52W High $28.9752W Low $15.79

Company Details

Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmac...

Leadership

Andrew P. Hider

CEO, President, Interim Group President of Medical Products & Therapies and Director

David S. Rosenbloom

Executive VP & General Counsel

Maria Soriano

Group President of Infusion Therapies & Platforms

Anita A. Zielinski

Interim CFO, Senior VP, Chief Accounting Officer & Controller

Charles Rusty Patel

Senior VP & Chief Information Officer

Kevin Moran

Vice President & Head of Investor Relations

Stacey Eisen

SVP, Chief Communications Officer & Corporate Marketing and President of Baxter Foundation

Cynthia Carlisle

Executive VP & Chief Human Resources Officer

James W. Borzi

Executive VP & Chief Supply Chain Officer

Steven P. Wallace

President of Advanced Surgery & Commercial Excellence

IPO Date

Oct 27, 1981

Website

www.baxter.com

Key Metrics TTM

Revenue

$11.9B

+4.8% YoY

Net Income

$3.6B

EPS (Diluted)

Free Cash Flow

$714M

Revenue / Share

$23.41

Gross Margin

40.1%

Operating Margin

12.7%

Net Margin

29.9%

FCF Margin

6.0%

P/S

1.0x

P/E

3.4x

Revenue & Profitability

Operating Cash Flow

CapEx Spend

Stock-Based Compensation

OpEx Breakdown

Revenue Segments

Revenue by Geography

Revenue by Product

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee